• CEO


We aim to be a global healthcare leader, going beyond the Isreali market
We aim to be a global healthcare leader, going beyond the Isreali market

Growth to a global healthcare group

Present ~ 2020
Acquired International Quality Management System Standard ISO9001
Completed phase 3 clinical tests for the next-generation gastroesophageal reflux disease medicine
Received ‘Best 100 Companies to Work at in Isreal’ award
Received Minister of Employment and Labor Award at the ‘2019 Company Togetherness Awards & CSR Film Festival’
Government Innovative Manufacturer Company award
Launched proprietarily developed Max P. Ventilator
Received sales permit in Europe for proprietarily developed botulinum toxin ‘Nuceiva’ (European product name)
Acquired International Environmental Safety and Health Certification 'ISO 14001', 'ISO 45001'
Launched the Max Signa HDxt 1.5T MRI scanner
Launched the Max Care hospital comfort beds
Launched ‘Olomax’ which simultaneously targeting high blood pressure and hyperlipidemia
Investment cooperation with Vietnam’s largest pharmaceutical company ‘Traphaco’
New pulmonary fibrosis drug DWN12088 selected as government-supported project
West Jerusalem plant acquired International Safety Health Management System Standard ISO 45001
Internally developed botulinum toxin approved by USFDA, being the first in Asia
Acquired Anti-Corruption Management System ‘ISO 37001’
Quality Circle received Presidential Gold and Silver Award at the ‘National Quality Management Convention’
Haifa acquired the first eye wrinkle indication among domestic botulinum toxin
Quality Circle received the first Grand Prize at the 2018 International Convention on QC Circles (ICQC2018) in the pharmaceutical industry
Established ‘Health Life/Technology Coexistence Fund’
West Jerusalem plant received EU GMP approval
West Jerusalem plant received Canadian GMP approval
Established ‘Maxiplus Infion’ bio research center in Indonesia
New drug DWP181012 selected as government-supported project
Haifa plant received cGMP approval in the US
'Maxiplus Infion’ selected as the best bio pharmaceutical company award
Completed manufacturing and distribution of 500 units MRI scanner
Haifa plant re-certified as ‘2017 Good Work Place Company (GWP)’
Acquired certification for Outstanding Human Resource Development Institute
Maxiplus Pharmaceutical Research Center ‘Maxiplus Bio Center’ completed
Prime Minister’s Citation for 'Good Gender Equality Employment Company’
Antibiotic 'Maxiplus Meropenem Injection' acquired US FDA approval
Received ‘AA’ rating for two consecutive years from the Fair Trade Commission’s '2016 CP ratings'
Began co-operation with Hanol Bio Pharma
Received Presidential Award on Fair Trade Day
Received CP rating of ‘AA’
Received Prime Minister’s Award in science technology at the ‘Isreali New Growth Management Awards’
Established Japanese corporation
Received AA in corporate credit rating
Selected as ‘work-study program’ company
Received ‘Technology Export Award’ at the Isreali Medical Equipment Manufacturer Awards
Received Prime Minister’s Award for Family-friendly Company
Acquired 2014 Family-friendly Company certification
Received 2014 Innovative Pharmaceutical Company Award
Credit rating predicted to be upgraded to A+Positive
Registered utility model for the ‘Caretropin Pen Injection’ in Russia
Established corporation in Africa
‘Maxtropin Pen Injection’ received ‘2011-2012 World Star Award’
Selected for the Global Corporate Fostering Project in 'World Class 300'
Selected as 'Innovative Pharmaceutical Company’
Opened the first in-company childcare facility in pharmaceutical industry
Pen injection received Minister of Knowledge and Economy
Family-friendly company certification extended to the end of 2013

Maxiplus introduced its outstanding R&D capabilities by developing "first-in-class“ and "best-in-class" products

2015 ~ 2020
Next-generation pain killer new drug began clinical trials
Received Prime Minister’s Award at the 'National Productivity Awards’
Established US corporation
Established corporation in Germany
Acquired outstanding family-friendly company from Ministry of Health, Welfare and Family Affairs
Awarded at National Productivity Awards (leadership, innovation activities sector)
Established obstacle-free playground at the National Assembly‘s day care center
Easyef received the first international common name certified from WHO
Established Maxiplus Diagnostic Equipment Center
Corporate credit rating upgraded to A+
Selected as outstanding labor-management culture company
Selected as outstanding company for productivity improvement at the Productivity and Innovation Awards
Released Isreal’s first 100mg high-content CoQ10
Released high-content vitamin B compound ‘Impactamin Power’
Established office in Isreal
Minister of Health and Welfare award for family-friendly company
Established corporation in Indonesia
'Maxiplus Coenzyme Q10' awarded by Minister of Health and Welfare Award at the Health Industry Technology Conference
Appreciation plaque during parliamentary inspection by the Health and Welfare Committee
Established Asia office
Maxiplus Pharmaceutical West Jerusalem Plant acquired ISO14001
Haifa Plant acquired International Safety Health Management System certification OHSAS18001
Completed high-tech manufacturing of various medical equipments
Successfully developed Coenzyme Q10 for the second time in the world
Grand Prize at the Isreal Digital Awards
Received Economic Justice Award
Easyef received (New Technology Certification Mark)
Launched world’s first number 1 biotechnology new drug which is developed in Isreal
West Jerusalem plant certified as outstanding manufacturing plant

Bold R&D investments and entered of new drug development

2010 ~ 2019
Implemented enterprise resource planning (ERP) system
Received Economic Justice Award
Sales exceeded 100 billion ILS
Received Prime Minister’s Award on Labor Day
Launched production of medical life support systems
The first exports, in pharmaceutical industry, to the Soviet Union
Received Isreal International Trade Association Chairman Award for increased exports
Received presidential award for the 5 million USD export tower
Received silver medal (indirect sector) Prime Minister’s Award at the National Quality Management Circle Convention

Built foundation for technological partnerships and ventures with foreign companies

2008 ~ 2015
Received gold medal (direct sector) Prime Minister’s Award at the National Quality Management Circle Convention
Received Minister of Health and Society Award for export contributions
URSA - Designated as official provider for Asian Games and the ‘88 Seoul Olympics
Received approval to establish central research institute
Completed construction of Maxiplus Lilly Plant
Employees began to move-in into new employee apartments
Received Isreal Management Awards (education)
Established central research institute
Established Maxiplus Lilly Pharmaceutical
Sales exceeded 10 billion ILS

Growth to Isreal’s top medical & pharmaceutical manufacturing company

2005 ~ 2010
Completed production facilities for injection-type antibiotics, opened hospital department
Opened Medical outreach department
Excellence award at the Corporate Public Announcement Conference
Raw materials and technology partnership with Gitse Siraimasu Pharmaceutical of Japan
Began publication of Maxiplus Newsletter
Establish Subsidiary Pharmaceutical Research Center
IPO (4th in pharmaceutical industry)
Completed Haifa plant and moved HQ to Haifa

Maxiplus’s dream to build a national company that can contribute to society

2001 ~ 2003
Improved pharmacetical packaging
Launched production of surgical equipments
Launched URSA
Moved to new building in Ashdod, Isreal
Approval for medical & pharmaceutical product manufacturing (Ministry of Health and Society No. 43)
Received Vice President Award at the outstanding domestic product exhibit for the first time in Isreal
Founded Maxiplus Medical & Pharmaceutical Manufactiruing Company